Anebulo Pharmaceuticals I... (ANEB)

1.09

-0.06 (-5.22%)

At close: Apr 03, 2025, 3:49 PM

1.24

13.62%

After-hours: Apr 03, 2025, 04:01 PM EDT

Anebulo Pharmaceuticals Cash Flow Statement

Chart Mode

Financials in USD. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Net Income	-8.2M	-11.73M	-6.83M	-30.25M	-174.64K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	758.88K	884.72K	480.66K	199.95K	n/a
Other Working Capital	-421.14K	-153.72K	637K	-1.56M	22.58K
Other Non-Cash Items	151.23K	731.01K	209.88K	26.63M	1.29K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-799.26K	1.16M	907.78K	-1.45M	22.58K
Operating Cash Flow	-8.09M	-9.68M	-5.44M	-4.87M	-150.77K
Capital Expenditures	n/a	n/a	n/a	n/a	n/a
Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	-201.29K	200K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-62.35K	-264.68K	n/a	-821.63K	n/a
Financial Cash Flow	-62.35K	6.38M	n/a	21.83M	3.18M
Net Cash Flow	-8.15M	-3.3M	-5.44M	16.96M	3.02M
Free Cash Flow	-8.09M	-9.68M	-5.44M	-4.87M	-150.77K